A systematic review of case reports on mortality, modes of infection, diagnostic tests, and treatments for Nipah virus infection

Revision as of 01:59, 7 February 2026 by Nhmkerala (talk | contribs) (Created paper page - 2026-02-07T07:29:03.140672)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Authors: Deekshitha Alla, Dhruv Jayeshkumar Shah, Navaneethan Adityaraj, Moparthi Vagdevi, Sai Santhosha Mrudula Alla, Krithi Sree, Praneeth Aitha, Ram Prasanjith Reddy Bollampalli, Antony Joseph Pathinangil, Krupa Patel, Yussif Issaka

Year: 2024

Journal: Medicine®

DOI: 10.xxxx/xxxxx or null

PMID: PMID or null

Summary

This paper conducts a systematic review of case reports on Nipah virus infection to examine geographic distribution, mortality, transmission pathways, and available methods for diagnosis and treatment.

Key Findings

  • 80% frequency of fever, 47% myalgia, 47% headache, 44.1% shortness of breath/acute respiratory distress syndrome, 44.1% altered sensorium, and 42.6% vomiting.
  • RT-PCR is the most commonly used diagnostic test.
  • Direct human contact with infected patients is the most common route of transmission.
  • Treatment modalities include interventional procedures, antiviral drugs, and symptomatic treatment.
  • Seizures (39.2%) and altered sensorium (35.7%) are the most common complications.

Methodology

  • Study Type: Systematic Review
  • Sample Size: N = 92 cases analyzed from 12 studies
  • Geographic Focus: Asia
  • Time Period: Years not specified

Topics

Epidemiology, Virology, Clinical

Relevance

The review emphasizes the importance of early Nipah virus infection diagnosis and treatment to prevent life-threatening consequences.

Source

View the entire paper: File:Medi-103-e39989.pdf